U.S. Professional Services Stock News

DigitalOcean Holdings (NYSE:DOCN) has acquired Katanemo Labs, including its open source AI agent management platform, Plano. Katanemo’s CEO is joining DigitalOcean as Senior Vice President of AI, expanding AI leadership at the company. The deal moves DigitalOcean further into the operational layer of agentic AI systems and AI agent lifecycle management. DigitalOcean is best known for serving developers and smaller businesses with cloud infrastructure and AI tooling, focusing on simplicity...

Recent trading context for NIQ Global Intelligence NIQ Global Intelligence (NIQ) has drawn investor attention after recent trading, with shares closing at US$11.48. The stock shows a 0.9% gain over the past day and a 12.3% move over the past week. See our latest analysis for NIQ Global Intelligence. The recent 12.3% 7 day share price return follows a weaker period, with both the 30 day and year to date share price returns showing a decline of around 27%. This suggests that momentum has...

Tariff shift puts Tootsie Roll Industries (TR) in focus Fresh interest in candy stocks has picked up after cocoa tariffs were lifted, easing a key input cost just as seasonal demand stays supportive for Tootsie Roll Industries (TR) and its confectionery peers. See our latest analysis for Tootsie Roll Industries. At a share price of $43.73, Tootsie Roll Industries has seen momentum build recently, with a 30 day share price return of 5.65% and a year to date share price return of 27.20%,...

For investors wondering if Turning Point Brands at around US$72.16 is still offering value or if the easy gains are behind it, this article focuses squarely on what the current price might be implying. The stock has pulled back sharply in the short term, with a 15.5% decline over the last 7 days and a 21.9% decline over the last 30 days, even though the 1 year return sits at 32.8% and the 3 year return is 254.2%. Recent market attention has centered on how this performance, including a year...

In recent days, analysts at Barclays and B. Riley Securities reaffirmed positive ratings on Martin Marietta Materials, even as the company faces weaker demand, revenue softness, and pressure on profitability. This contrast between analyst optimism and the company’s recent 1.7% revenue decline and lower returns on capital highlights a growing debate over its long-term earnings power. We’ll now examine how B. Riley’s upgrade, against a backdrop of sector headwinds, affects Martin Marietta’s...

In late March 2026, Golar LNG Limited filed an omnibus shelf registration covering a broad range of securities and separately began a formal review of options such as a sale, merger, asset divestitures, or corporate structure changes to accelerate its Floating Liquefied Natural Gas (FLNG) growth plans. This combination of financing flexibility and a wide-ranging review of potential transactions highlights how Golar is reassessing how best to monetize its FLNG platform, long-term contract...

Recent analyst activity around Valvoline (VVV), including reaffirmed positive ratings and upgrades from several brokerage firms, has drawn fresh attention to the stock and raised questions about how current expectations compare with its fundamentals. See our latest analysis for Valvoline. Despite the recently reaffirmed positive ratings, Valvoline’s latest share price of $33.33 sits below its recent high point, with a 30 day share price return showing a decline of 7.57%. However, the 90 day...

BlackSky Technology (NYSE:BKSY) received a sole source, multi year US$99 million IDIQ contract from the U.S. government. The award comes from the Air Force Research Laboratory and targets advanced optical payload and next generation space intelligence capabilities. The contract focuses on large aperture optical systems and AI enabled space data tools that differ from BlackSky's existing Gen 2 and Gen 3 offerings. For readers tracking NYSE:BKSY, this contract sits at the center of the...

ArriVent BioPharma (AVBP) has drawn attention after recent trading, with the share price closing at US$24.89. Investors are weighing this clinical stage cancer drug developer’s profile against its current valuation signals. See our latest analysis for ArriVent BioPharma. That closing share price of US$24.89 comes after a 2.77% 1 day share price return and a 16.15% 7 day share price return. The 30 day share price return of 1.43% contrasts with a 19.66% 90 day share price return and a 51.58% 1...

Royalty Pharma (NasdaqGS:RPRX) has entered into a new R&D co-funding agreement with Johnson & Johnson to develop a novel autoimmune therapy. The company has also appointed a Head of Artificial Intelligence to expand the use of advanced analytics and data science across its operations. These announcements mark a shift toward greater involvement in drug development and data driven decision making. Royalty Pharma, known primarily for acquiring biopharma royalties, typically gives investors...

In recent weeks, Crescent Energy’s position as a top 10 independent U.S. oil and gas producer has been reinforced by its multi–billion‑dollar Vital Energy acquisition and stronger investor attention amid heightened Middle East tensions that have lifted crude prices and earnings expectations across the sector. The combination of a larger Permian-focused asset base, rising free cash flow, and an expanding royalties business is now reshaping how Crescent Energy is grouped and compared within...

Regulators allowed the Hart Scott Rodino antitrust waiting period for Coterra Energy's merger with Devon Energy to expire, clearing a key hurdle. This approval means Coterra Energy (NYSE:CTRA) can move toward closing, with the company expected to become a wholly owned subsidiary of Devon. The companies currently anticipate closing the transaction in Q2 2026, subject to remaining customary conditions. Coterra Energy focuses on oil and gas exploration and production, an area where scale, cost...

Wix.com (NasdaqGS:WIX) completed a modified Dutch auction share repurchase, buying back nearly 30% of its outstanding shares. The buyback reduces Wix's share count and follows a period of increased focus on AI driven product investments. The transaction comes as some analysts lower their ratings on the stock, even as the company continues to invest in growth initiatives. Wix.com runs a global website creation and business management platform used by individuals, small businesses, and larger...

Belite Bio (BLTE) drew attention after its Phase 3 DRAGON trial met the primary endpoint for Tinlarebant, alongside a US$402 million public offering that supports its planned NDA submission and early commercialization work. See our latest analysis for Belite Bio. The trial success and funding news sit against a share price of US$169.85, with a 7 day share price return of 11.69% but a 30 day share price return decline of 1.58%. The 1 year total shareholder return of 198.51% and 3 year total...

Executive change triggers fresh look at Ardent Health stock Ardent Health (ARDT) shares are in focus after the company announced that Ethan Chernin, President of Hospital Services, departed on March 24, 2026, under its executive severance plan, prompting investors to reassess leadership stability and valuation. See our latest analysis for Ardent Health. With the latest close at $8.66, Ardent Health has seen a 1 month share price return of 8.26% decline and a 1 year total shareholder return of...

Geopolitics and recent price swings Murphy Oil (MUR) has been moving in step with oil market swings tied to the U.S. Iran conflict, with rising tensions lifting the share price and later de escalation headlines reversing part of that move. See our latest analysis for Murphy Oil. Beyond the latest geopolitical swings, Murphy Oil’s 1 month share price return of 19.87% and year to date gain of 26.44% sit alongside a very large 5 year total shareholder return of 193.69%, suggesting momentum that...

Vontier Corporation recently entered into a 364-day senior unsecured term loan agreement for a US$300 million facility maturing on March 30, 2027, with interest tied to Term SOFR or a base rate plus ratings-based margins, to help repay 2026 senior unsecured notes and fund general corporate purposes. This short-term, unsecured financing underscores lenders’ confidence in Vontier’s credit profile while reshaping its near-term capital structure and liquidity position. We’ll now examine how...

Excelerate Energy (EE) is back in focus after officially naming and commissioning its newest floating storage and regasification unit, Excelerate Acadia, in South Korea. This highlights continued investment in LNG infrastructure capacity. See our latest analysis for Excelerate Energy. The share price has pulled back recently, with a 1 month share price return of 8.52% and a 7 day share price return of a 2.12% decline, even after a 90 day share price return of 15.56% and a 1 year total...

Why Knowles matters for investors right now Knowles (KN) has quietly drawn attention after a strong past 3 months, with total return above 17%, while its latest figures show US$593.2 million in revenue and US$50.9 million in net income. See our latest analysis for Knowles. At a share price of US$25.87, Knowles has given investors a 17.86% year to date share price return and a 102.74% total shareholder return over the past year, pointing to firm positive momentum that contrasts with a modest 1...

Vaxcyte (PCVX) recently reported full enrollment in its OPUS-1 and OPUS-2 Phase 3 trials for VAX-31, a key step toward a potential Biologics License Application that investors often monitor closely. See our latest analysis for Vaxcyte. The recent completion of enrollment in the OPUS-1 and OPUS-2 trials comes alongside strong momentum, with a 90 day share price return of 25.66% and a 1 year total shareholder return of 84.75%, while the latest share price stands at US$58.38. If this kind of...

In March 2026, Sun Communities’ audit committee replaced Grant Thornton with Deloitte & Touche as its independent auditor for the 2026 fiscal year, while analysts at Mizuho and BMO initiated or reiterated positive coverage highlighting the company’s manufactured housing and RV-focused business. Analysts also pointed to the potential sale of Sun’s UK Parks Holiday business and recent US$457 million of manufactured housing acquisitions as key ways to sharpen the company’s focus on core,...

Alkami Technology recently expanded its board to 11 members by appointing Jeffrey Fox and Judson Linville as new directors, each bringing decades of experience in financial services, technology, and corporate leadership. The addition of a seasoned fintech and card-services executive alongside an investment and operations-focused CEO signals a stronger emphasis on scaling Alkami’s platform and tightening execution discipline. We’ll now examine how the MANTL partnership with Aloha Pacific...

Ardelyx, Inc. recently appointed Rajani Dinavahi, MD, as Chief Medical Officer, effective April 1, 2026, bringing more than two decades of biotech and clinical leadership across nephrology, immunology, and cell therapy. Her experience guiding complex therapies from early development through Phase 3 and regulatory approval could meaningfully shape Ardelyx’s clinical execution and medical affairs priorities. We’ll now examine how Dr. Dinavahi’s extensive nephrology and immunology background...

Sonos (SONO) just delivered a quarter where revenue, earnings per share, and adjusted operating income all came in ahead of analyst estimates, and CEO Tom Conrad described fiscal 2026 as off to a good start. See our latest analysis for Sonos. The share price tells a mixed story, with a 7 day share price return of 6.93%, a 30 day share price return showing a 10.66% decline, and a 90 day share price return showing a 22.36% decline. The 1 year total shareholder return of 58% suggests longer term...